GSA Capital Partners’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,464
| Closed | -$366K | – | 1704 |
|
|
2025
Q1 | $366K | Buy |
+18,464
| New | +$366K | 0.03% | 1015 |
|
|
2024
Q4 | – | Sell |
-35,313
| Closed | -$706K | – | 1564 |
|
|
2024
Q3 | $706K | Sell |
35,313
-109,045
| -76% | -$2.18M | 0.05% | 680 |
|
|
2024
Q2 | $1.61M | Buy |
144,358
+9,429
| +7% | +$105K | 0.11% | 239 |
|
|
2024
Q1 | $891K | Buy |
134,929
+118,215
| +707% | +$781K | 0.07% | 516 |
|
|
2023
Q4 | $76K | Sell |
16,714
-225,570
| -93% | -$1.03M | 0.01% | 1410 |
|
|
2023
Q3 | $867K | Buy |
242,284
+113,184
| +88% | +$405K | 0.07% | 478 |
|
|
2023
Q2 | $476K | Buy |
129,100
+61,626
| +91% | +$227K | 0.05% | 773 |
|
|
2023
Q1 | $223K | Sell |
67,474
-100,948
| -60% | -$334K | 0.02% | 1202 |
|
|
2022
Q4 | $653K | Buy |
+168,422
| New | +$653K | 0.08% | 435 |
|
|
2022
Q1 | – | Sell |
-96,578
| Closed | -$136K | – | 1363 |
|
|
2021
Q4 | $136K | Sell |
96,578
-508,659
| -84% | -$716K | 0.02% | 1283 |
|
|
2021
Q3 | $684K | Sell |
605,237
-255,674
| -30% | -$289K | 0.07% | 510 |
|
|
2021
Q2 | $1.38M | Buy |
860,911
+311,287
| +57% | +$498K | 0.15% | 141 |
|
|
2021
Q1 | $967K | Buy |
549,624
+222,572
| +68% | +$392K | 0.16% | 140 |
|
|
2020
Q4 | $638K | Buy |
327,052
+93,627
| +40% | +$183K | 0.1% | 287 |
|
|
2020
Q3 | $558K | Buy |
+233,425
| New | +$558K | 0.09% | 326 |
|
|
2020
Q2 | – | Sell |
-121,258
| Closed | -$349K | – | 583 |
|
|
2020
Q1 | $349K | Buy |
121,258
+75,174
| +163% | +$216K | 0.09% | 386 |
|
|
2019
Q4 | $184K | Buy |
+46,084
| New | +$184K | 0.02% | 1279 |
|